India's Morepen Laboratories slips after quarterly profit fall
27/05/2026 05:33
BUZZ-India's Morepen Laboratories slips after quarterly profit fall ** Shares of India's Morepen Laboratories MORL.NS fall 4.8% to 41.81 rupees
** Pharma firm's Q4 consol net profit fell 22.7% y/y to 157 million rupees ($1.64 million)
** Total expenses rose about 5.7%, outpacing revenue from operations rise of 4%
** YTD, stock up nearly 1.4%
($1 = 95.7550 Indian rupees)
(Reporting by Bipasha Dey in Bengaluru)
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall